Navigation Links
New All-Natural Dietary Supplement Made from Muscadine Grape Skins Helps Inhibit Growth of Certain Cancers
Date:10/10/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... Cosmetic Town Journal is ... need to have a successful cosmetic procedure; from publishing encyclopedic medical articles to ... is always ready to help. , It is clear that the Cosmetic Town ...
(Date:8/31/2015)... ... ... to undergoing a hair transplant, most patients have donor hair moved from one part of ... on top of the scalp, as well as filling in areas missing hair, is a ... areas of their head. , What about patients who have a limited, or even depleted, ...
(Date:8/31/2015)... ... 2015 , ... The Lisle family law firm of Momkus McCluskey, LLC ... his peers to earn a “Leading Lawyers” distinction. , The “Leading ... of Illinois. The nomination process is based on statewide peer survey nominations and the ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... as Vice President, Marketing and Corporate Communications. In this capacity, Michael will provide ... CareSource is an industry leader in consumer-focused programs that have contributed to the ...
(Date:8/31/2015)... ... 2015 , ... The Sundance Film Festival award winning documentary “Alive Inside” is ... shadows a social worker who advocates for the use of music therapy for dementia ... to residents in health care centers who may have lost a spark in life ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2
... Jan. 8 Cephalon, Inc. (Nasdaq: CEPH ) has scheduled its regular quarterly ... EST on Thursday, February 11, 2010. , February 11, 2010 Schedule ... 2009 results will be distributed by PRNewswire, 4:50 p.m. EST ... and refer ...
... , , - ... , PHILADELPHIA, Jan 8 Children with autism spectrum disorders ... than children without ASDs, and measuring magnetic signals that mark this ... (Photo: http://www.newscom.com/cgi-bin/prnh/20100108/DC34671 ) , Researchers at The Children,s ...
... SAN FRANCISCO, Jan. 8 The following is a statement ... groundbreaking for the Family Violence Prevention Fund,s International Center: ... objective of Blue Shield of California,s charitable endeavors for more ... signature contribution to the Family Violence Prevention Fund,s International Center ...
... , CANTON, Mass., Jan. 8 ... the New Year with an expanded line-up of BRight Choices(TM) ... including fat free, dairy free, no sugar added and light ... BRight Choices flavors have all the great taste and quality ...
... the January 2010 issue of the Journal of ... efficacy of the recent reclassification of the T category ... The medical records of 1,393 patients with non-small cell ... for pathologic findings and survival. The stage of all ...
... such as X-ray CT, ultrasound imaging and MRI, doctors have ... on inside a patient,s body, and now a Texas A&M ... to do so. , The professor, Peter Kuchment, a leading ... may enhance the process for detecting cancer and many other ...
Cached Medicine News:Health News:Cephalon Fourth Quarter & Full Year 2009 Earnings Conference Call Thursday, February 11, 2010 at 5:00 p.m. EST 2Health News:Brain Imaging May Help Diagnose Autism 2Health News:Brain Imaging May Help Diagnose Autism 3Health News:Brain Imaging May Help Diagnose Autism 4Health News:Baskin-Robbins Helps Kick-Start New Year's Resolutions With New Better-For-You BRight Choices(TM) Treats 2Health News:Baskin-Robbins Helps Kick-Start New Year's Resolutions With New Better-For-You BRight Choices(TM) Treats 3Health News:Research confirms efficacy of the newly reclassified TMN staging system 2Health News:Texas A&M prof working on new ways to see through the human body 2
(Date:8/31/2015)... -- Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX ), a late-stage ... Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical ... investor conferences in September. , ... LLC Emerging Growth Conference in New ... President & Chief Executive Officer, will present a corporate ...
(Date:8/31/2015)... , August 31, 2015 ... BOLT, OTCQX: BLGTY) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, today announced ... MCTC), has identified several new genetic markers with ... in patients treated with bisphosphonate drugs and was ...
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... dosed at Chicago -based Rush ... trial evaluating activity of escalating doses of AST-OPC1 ... sensory and motor complete cervical spinal cord injury ...
Breaking Medicine Technology:Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... Calif., Oct. 7 Onyx Pharmaceuticals, Inc. (Nasdaq: ... its New Drug Application (NDA) filing for carfilzomib based ... Controls (CMC) review division of the U.S. Food and ... information related to commercial-scale manufacturing of carfilzomib.  Onyx had ...
... NEW YORK, Oct. 7 Reportlinker.com announces that a ... European RIS/PACS Market ... European RIS/PACS market in terms of the challenges faced ... The main chapters of the research service include an ...
Cached Medicine Technology:Onyx Pharmaceuticals Provides Status Update on Carfilzomib 2Onyx Pharmaceuticals Provides Status Update on Carfilzomib 3Reportlinker Adds European RIS/PACS Market 2Reportlinker Adds European RIS/PACS Market 3
... is an Anterior Cervical Plating System ... flexibility and simplicity for the spinal ... function and safe fixation of the ... meet the needs of the spinal ...
... cervical spinal compression plate acc. to Matzen ... the cervical spine (HWS) with the exception ... immobilization of the fusion length until the ... fixed anteriorly on the vertebral bodies, if ...
The Codman anterior cervical plate is designed for immediate internal fixation of the cervical spine following bone grafting procedures....
... small things. The extremely small,HiLAN XS ... trailblazers of the new,generation of miniaturized ... smaller access and the demand for ... HiLAN XS motor concept is the ...
Medicine Products: